Search Results - "Hendriksz, T.R."

  • Showing 1 - 6 results of 6
Refine Results
  1. 1

    Long-term safety and efficacy of a tamoxifen-based treatment strategy for idiopathic retroperitoneal fibrosis by van Bommel, E.F.H, Pelkmans, L.G, van Damme, H, Hendriksz, T.R

    Published in European journal of internal medicine (01-07-2013)
    “…Abstract Background Tamoxifen may be a viable treatment option for idiopathic retroperitoneal fibrosis (iRPF) but data are limited and its long-term safety and…”
    Get full text
    Journal Article
  2. 2

    18F-fluorodeoxyglucose position emission tomography (FDG-PET) for monitoring disease activity and treatment response in idiopathic retroperitoneal fibrosis by Jansen, I., Hendriksz, T.R., Han, S.H., Huiskes, A.W.L.C., van Bommel, E.F.H.

    Published in European journal of internal medicine (01-06-2010)
    “…To evaluate the value of 18F-fluorodeoxyglucose positron emission tomography (FDG-PET) in monitoring disease activity and predicting treatment response in…”
    Get full text
    Journal Article
  3. 3

    Elevated serum IgG4 levels in diagnosis and treatment response in patients with idiopathic retroperitoneal fibrosis by Pelkmans, L.G., Hendriksz, T.R., Westenend, P.J., Vermeer, H.J., van Bommel, E.F.H.

    Published in Clinical rheumatology (01-04-2017)
    “…Idiopathic retroperitoneal fibrosis (iRPF) may be a manifestation of IgG4-related disease. Measuring serum IgG4 (sIgG4) may be of value in monitoring iRPF, but…”
    Get full text
    Journal Article
  4. 4

    Predicting reinterventions after open and endovascular aneurysm repair using the St George's Vascular Institute score by de Bruin, Jorg Lucas, MD, Karthikesalingam, Alan, PhD, Holt, Peter J., PhD, Prinssen, Monique, PhD, Thompson, Matt M., MD, Blankensteijn, Jan D., PhD

    Published in Journal of vascular surgery (01-06-2016)
    “…Background Identifying patients at risk for aneurysm rupture and sac expansion after open and endovascular abdominal aortic aneurysm (AAA) repair (EVAR) may…”
    Get full text
    Journal Article
  5. 5

    18 F-fluorodeoxyglucose position emission tomography (FDG-PET) for monitoring disease activity and treatment response in idiopathic retroperitoneal fibrosis by Jansen, I, Hendriksz, T.R, Han, S.H, Huiskes, A.W.L.C, van Bommel, E.F.H

    “…Abstract Objective To evaluate the value of18 F-fluorodeoxyglucose positron emission tomography (FDG-PET) in monitoring disease activity and predicting…”
    Get full text
    Journal Article
  6. 6